COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities
暂无分享,去创建一个
A. Harky | Eyad Abuelgasim | Amer Harky | Eyad Abuelgasim | Li Jing Saw | Manasi Shirke | Mohamed Zeinah | Mohamed Zeinah | M. Shirke | M. Zeinah
[1] E. W. Mitchell,et al. Public Response to Community Mitigation Measures for Pandemic Influenza , 2008, Emerging infectious diseases.
[2] J. Kuhn,et al. The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2 , 2007, Virology.
[3] Keith C. Norris,et al. The Role of Ethnic Variation and CKD. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[4] L. Lynch. Intensive Care National Audit and Research Centre (ICNARC) , 2002 .
[5] E. Schiffrin,et al. Hypertension and COVID-19 , 2020, American journal of hypertension.
[6] A. Harky,et al. ACE inhibitors and COVID‐19: We don't know yet , 2020, Journal of cardiac surgery.
[7] G. Fey,et al. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor , 2004, Biochemical and Biophysical Research Communications.
[8] David A. Jolliffe,et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data , 2017, British Medical Journal.
[9] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[10] H. Ho,et al. Glucose-6-Phosphate Dehydrogenase Deficiency Enhances Human Coronavirus 229E Infection , 2008, The Journal of infectious diseases.
[11] B. Boehm,et al. Endocrine and metabolic link to coronavirus infection , 2020, Nature Reviews Endocrinology.
[12] G. Rubin,et al. Health Protection Agency, , 2011 .
[13] M. McDonald,et al. Protection of racial/ethnic minority populations during an influenza pandemic. , 2009, American journal of public health.
[14] P. Burney,et al. Explaining ethnic disparities in lung function among young adults: A pilot investigation , 2017, PloS one.
[15] Sandra Crouse Quinn,et al. Racial disparities in exposure, susceptibility, and access to health care in the US H1N1 influenza pandemic. , 2011, American journal of public health.
[16] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[17] L. Donaldson,et al. Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study , 2010, The Lancet.
[18] W. Grant,et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths , 2020, Nutrients.
[19] K. Dickersin,et al. Defining race/ethnicity and explaining difference in research studies on lung function , 2012, European Respiratory Journal.
[20] D. Hui,et al. ACE2 Gene Polymorphisms Do Not Affect Outcome of Severe Acute Respiratory Syndrome , 2004, Clinical chemistry.
[21] A. Harky,et al. The role of biomarkers in diagnosis of COVID-19 – A systematic review , 2020, Life Sciences.
[22] B. Horta,et al. African ancestry, lung function and the effect of genetics , 2015, European Respiratory Journal.
[23] Bo Li,et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China , 2020, Clinical Research in Cardiology.
[24] P. Saunders,et al. The determinants of health-seeking behaviour during the A/H1N1 influenza pandemic: an ecological study , 2011, Journal of public health.
[25] S. Knapp,et al. Diabetes and Infection: Is There a Link? - A Mini-Review , 2012, Gerontology.
[26] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[27] C. Aranow. Vitamin D and the Immune System , 2011, Journal of Investigative Medicine.
[28] S. Al-Abdi,et al. G6PD deficiency in the COVID-19 pandemic: Ghost within Ghost , 2020, Hematology/Oncology and Stem Cell Therapy.
[29] Gonzalo H. Otazu,et al. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study , 2020, medRxiv.
[30] Ernest Beutler,et al. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. , 2009, Blood cells, molecules & diseases.
[31] J. Chan,et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[32] D. Beevers,et al. Management of hypertension in ethnic minorities , 2005, Heart.
[33] A. Harky,et al. Cancer Patient Care during COVID-19 , 2020, Cancer Cell.
[34] G. Lippi,et al. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection , 2020, International Urology and Nephrology.
[35] P. Gill,et al. Vitamin D deficiency amongst minority ethnic groups in the UK: a cross sectional study. , 2013, International journal of cardiology.
[36] J. E. Hansen,et al. Ethnic differences in pulmonary function in healthy nonsmoking Asian-Americans and European-Americans. , 2000, American journal of respiratory and critical care medicine.
[37] J. Stocks,et al. Lung function testing in children: importance of race and ethnic-specific reference equations , 2014, Expert review of respiratory medicine.
[38] R. Allard,et al. Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection , 2010, Diabetes Care.
[39] A. Harky,et al. COVID-19 and Multiorgan Response , 2020, Current Problems in Cardiology.
[40] A. Harky,et al. At the heart of COVID‐19 , 2020, Journal of cardiac surgery.